Back

LncRNA SNHG1 suppresses LPS-induced acute lung injury by regulating miR-421/TIMP3 axis

Chen, Y.; Jiang, Z.; Tan, J.; Yuan, Y.; Shen, J.

2021-02-05 immunology
10.1101/2021.02.04.429871 bioRxiv
Show abstract

Extensive evidence has revealed the crucial roles of long non-coding RNAs (lncRNAs) in acute lung injury (ALI). This study aimed to explore the mechanism of lncRNA SNHG1 in lipopolysaccharides (LPS)-induced ALI. RT-qPCR was employed to test the levels of SNHG1, miR-421 and TIMP3 in A549 cells. Cell viability and apoptosis were assessed by CCK-8 assay and flow cytometry. ELISA assay was adopted to examine the levels of inflammatory-related cytokines, including IL-1{beta}, IL-6 and TNF-. The binding sequences of miR-421 and SNHG1 or TIMP3 were predicted using starBase software. Then dual-luciferase reporter and RIP assays were adopted to verify the interaction between miR-421 and SNHG1 or TIMP3. The protein level of TIMP3 was measured by western blotting. It was found that LPS stimulation downregulated SNHG1 level and SNHG1 addition decreased viability, and induced apoptosis as well as promoted inflammatory responses in LPS-treated A549 cells. SNHG1 could sponge miR-421 and SNHG1 protected A549 cells from LPS-induced injury via inhibiting miR-421. Moreover, TIMP3 was a target of miR-421. MiR-421 silence protected A549 cells against the LPS-triggered inhibition in viability, and promotion in apoptosis and inflammatory responses. SNHG1 could upregulate TIMP3 through acting as a ceRNA of miR-421 in A549 cells. Altogether, the present study elaborated that SNHG1 inhibited LPS-stimulated ALI by modulating the miR-421/TIMP3 axis.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 15%
12.2%
2
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.1%
8.1%
3
International Immunopharmacology
15 papers in training set
Top 0.1%
6.4%
4
eLife
5828 papers in training set
Top 20%
5.6%
5
Life Sciences
27 papers in training set
Top 0.1%
4.2%
6
Frontiers in Immunology
638 papers in training set
Top 3%
3.5%
7
The FASEB Journal
194 papers in training set
Top 1%
2.9%
8
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.2%
2.5%
9
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.2%
2.2%
10
Biochemical and Biophysical Research Communications
84 papers in training set
Top 0.8%
2.0%
11
Journal of Cellular and Molecular Medicine
20 papers in training set
Top 0.2%
2.0%
50% of probability mass above
12
Cells
249 papers in training set
Top 3%
1.8%
13
International Journal of Molecular Sciences
494 papers in training set
Top 7%
1.8%
14
Scientific Reports
3612 papers in training set
Top 52%
1.8%
15
Frontiers in Cardiovascular Medicine
53 papers in training set
Top 2%
1.7%
16
Frontiers in Molecular Biosciences
102 papers in training set
Top 0.8%
1.5%
17
Heliyon
152 papers in training set
Top 4%
1.4%
18
Molecular Medicine
11 papers in training set
Top 0.2%
1.2%
19
Journal of Biomedical Science
17 papers in training set
Top 0.2%
1.1%
20
Bioscience Reports
27 papers in training set
Top 1%
1.1%
21
Journal of Immunology Research
12 papers in training set
Top 0.4%
1.1%
22
Cell Death & Disease
126 papers in training set
Top 3%
1.1%
23
BioMed Research International
28 papers in training set
Top 2%
1.1%
24
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.5%
1.1%
25
Free Radical Biology and Medicine
36 papers in training set
Top 0.6%
0.9%
26
Biomedicines
67 papers in training set
Top 2%
0.9%
27
Biochemistry and Biophysics Reports
30 papers in training set
Top 1%
0.9%
28
Microbial Pathogenesis
17 papers in training set
Top 0.3%
0.9%
29
Acta Pharmaceutica Sinica B
11 papers in training set
Top 0.3%
0.9%
30
Journal of Personalized Medicine
28 papers in training set
Top 1%
0.9%